BiopharmaTrend.com

Deargen

Deargen

Private company
DEARGEN

DEARGEN advances the treatment of rare and intractable diseases through the integration of AI and collective intelligence.
Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology.
It specializes in genome data analysis, biomarker prediction, molecule selection and optimization.
DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new drugs.


Founded
2016
Status
Private company
Geography
South Korea based
Patents
1

Products

Dr.UG

Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes …

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page